By Hicbd
Mon Nov 28 2022 1:02 pm
"Celmatix, a next-generation women’s health company, today announced Fertilome, a first-of-its-kind genetic screen that reveals how a woman’s DNA may influence her reproductive health. The test, which is available through physicians, gives women unique genetic insights, allowing them to proactively manage their reproductive health and long-term fertility potential. Fertilome is the result of nearly eight years of Celmatix research focused on the genetic factors associated with the most common reproductive conditions that can lead to fertility difficulties in women, including endometriosis, polycystic ovarian syndrome (PCOS), and primary ovarian insufficiency—a precursor to early menopause."
URL:----------------------------------------------------------
Please login to comment
